Clinical Trials Directory

Trials / Conditions / First-Line

First-Line

7 registered clinical trials studyying First-Line — 3 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingAnlotinib Plus Benmelstobart and AG in First-line Treatment of Advanced Metastatic Pancreatic Cancer (ALTER-PA
NCT06621095
RenJi HospitalPhase 2
RecruitingNALIRI-XELOX+AK104 for First-line Treatment of Advanced PDAC
NCT06405490
Cancer Institute and Hospital, Chinese Academy of Medical SciencesPhase 2
RecruitingXELOX +Bev +Tislelizumab for First-line Treatment of MSS/pMMR RAS-mutated mCRC
NCT05970302
Cancer Institute and Hospital, Chinese Academy of Medical SciencesPhase 2
UnknownTislelizumab Combined With Chemotherapy in First-line Treatment of AGC
NCT06034964
Cancer Institute and Hospital, Chinese Academy of Medical Sciences—
UnknownAttenuated SOX as First-line Treatment in Elderly Patients With Relapsed or Metastatic Gastric Cancer
NCT00961077
Soonchunhyang University HospitalPhase 2
UnknownMulti-center Trial of Revlimid® and Rituximab, for First-Line Treatment of Chronic Lymphocytic Leukemia (CLL)
NCT00628238
Chronic Lymphocytic Leukemia Research ConsortiumPhase 2
TerminatedTopotecan and Cisplatin Versus Etoposide and Carboplatin in 1st Line Treatment of Patients With Small Cell Lun
NCT00812266
Danish Oncological Lung Cancer GroupPhase 3